Azaindole derivatives as CFTR modulators

Details for Australian Patent Application No. 2007351454 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Miller, Mark; Zhou, Jinglan; Bear, Brian; Hadida Ruah, Sara

Agent Baldwins

Pub. Number AU-A-2007351454

PCT Pub. Number WO2008/127399

Priority 60/856,584 03.11.06 US

Filing date 2 November 2007

Wipo publication date 23 October 2008

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/127399 Priority application(s): WO2008/127399

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007351498-Organic compounds

2007351447-System and method for hydraulically managing fluid pressure downstream from a main valve between set points